Experimental Mouse Model of Bleomycin‐Induced Skin Fibrosis
Open Access
- 27 August 2019
- journal article
- research article
- Published by Wiley in Current Protocols in Immunology
- Vol. 126 (1) , e88
Abstract
Systemic sclerosis (SSc) refers to an autoimmune disease, which is manifested by inflammation, vasculopathy, and fibrosis of the skin and internal organs. There are a number of different animal models recapitulating specific aspects of SSc. The experimental mouse model of bleomycin‐induced skin fibrosis is commonly used to study the pathogenesis observed in SSc. In this model, repetitive intradermal injections of the cytotoxic agent bleomycin trigger progressive skin thickening, associated with excessive accumulation of collagen, infiltration of immune cells, and formation of α‐smooth muscle actin (α‐SMA)‐positive myofibroblasts. In this article, we provide a detailed protocol for the induction of skin fibrosis in experimental mice by bleomycin. Moreover, we describe procedures for processing and analyzing affected skin tissue, provide troubleshooting, highlight advantages and limitations of the presented model, and critically discuss representative results. © 2019 by John Wiley & Sons, Inc.Basic Protocol 1: Intradermal bleomycin injections to induce skin fibrosis in miceSupport Protocol: Mouse tissue collection for fibrosis evaluation and for other molecular assaysBasic Protocol 2: Evaluation of mouse skin thickness using Masson's trichrome stainingBasic Protocol 3: Measurement of hydroxyproline content in skin tissue using a colorimetric assayBasic Protocol 4: Evaluation of myofibroblasts in mouse skin by immunohistochemistryKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Novartis
This publication has 24 references indexed in Scilit:
- Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosisAnnals of the Rheumatic Diseases, 2013
- Health Evaluation of Experimental Laboratory MiceCurrent Protocols in Mouse Biology, 2012
- Animal models of systemic sclerosis: Prospects and limitationsArthritis & Rheumatism, 2010
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosisArthritis & Rheumatism, 2008
- CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced SclerodermaThe American Journal of Pathology, 2008
- Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavageNucleic Acids Research, 2008
- Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosisArthritis & Rheumatism, 2007
- EuthanasiaCurrent Protocols in Immunology, 2006
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Chronic graft-versus-host disease (GVHD) as a model for sclerodermaCellular Immunology, 1983